165 related articles for article (PubMed ID: 9040858)
1. Mucosal immunology and models of mucosal HIV infection.
Griffin GE; Castello-Branco LR; Ortigão-de-Sampaio MB; Shattock R
Mem Inst Oswaldo Cruz; 1996; 91(3):367-9. PubMed ID: 9040858
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal immune responses in HIV infected subjects.
Castello-Branco LR; Lewis DJ; Ortigõ-de-Sampaio MB; Griffin GE
Mem Inst Oswaldo Cruz; 1996; 91(3):363-6. PubMed ID: 9040857
[TBL] [Abstract][Full Text] [Related]
3. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
4. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
[TBL] [Abstract][Full Text] [Related]
5. Chemokines at mucosal barriers and their impact on HIV infection.
Rancez M; Couëdel-Courteille A; Cheynier R
Cytokine Growth Factor Rev; 2012; 23(4-5):233-43. PubMed ID: 22728258
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
George MD; Asmuth DM
Curr Opin Infect Dis; 2014 Jun; 27(3):275-81. PubMed ID: 24739345
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.
Kaul R; Plummer FA; Kimani J; Dong T; Kiama P; Rostron T; Njagi E; MacDonald KS; Bwayo JJ; McMichael AJ; Rowland-Jones SL
J Immunol; 2000 Feb; 164(3):1602-11. PubMed ID: 10640781
[TBL] [Abstract][Full Text] [Related]
8. Mucosal junctions: open doors to HPV and HIV infections?
Herfs M; Hubert P; Moutschen M; Delvenne P
Trends Microbiol; 2011 Mar; 19(3):114-20. PubMed ID: 21216598
[TBL] [Abstract][Full Text] [Related]
9. Beast in the belly. A new focus on early HIV infection in the gut and other mucosal tissues may generate novel strategies to study, treat, and prevent infection.
Cohen P
IAVI Rep; 2006; 10(2):1-5. PubMed ID: 16721993
[No Abstract] [Full Text] [Related]
10. M cells and the pathogenesis of mucosal and systemic infections.
Siebers A; Finlay BB
Trends Microbiol; 1996 Jan; 4(1):22-9. PubMed ID: 8824791
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunity and microbial pathogenicity.
Autenrieth IB
Int J Med Microbiol; 2003 Apr; 293(1):1. PubMed ID: 12755362
[No Abstract] [Full Text] [Related]
12. Mucosal T cell response to reovirus.
Chen D; Rubin DH
Immunol Res; 2001; 23(2-3):229-34. PubMed ID: 11444387
[TBL] [Abstract][Full Text] [Related]
13. Antigen sampling by epithelial tissues: implication for vaccine design.
Kraehenbuhl JP; Hopkins SA; Kernéis S; Pringault E
Behring Inst Mitt; 1997 Feb; (98):24-32. PubMed ID: 9382745
[TBL] [Abstract][Full Text] [Related]
14. The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.
Randall TD; Mebius RE
Mucosal Immunol; 2014 May; 7(3):455-66. PubMed ID: 24569801
[TBL] [Abstract][Full Text] [Related]
15. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers.
Iqbal SM; Ball TB; Kimani J; Kiama P; Thottingal P; Embree JE; Fowke KR; Plummer FA
J Infect Dis; 2005 Sep; 192(5):728-38. PubMed ID: 16088822
[TBL] [Abstract][Full Text] [Related]
16. The mucosal immune system and HIV-1 infection.
Veazey R; Lackner A
AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
Belyakov IM; Ahlers JD
Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
[TBL] [Abstract][Full Text] [Related]
18. M cells as portals of infection: clinical and pathophysiological aspects.
Fujimura Y; Owen RL
Infect Agents Dis; 1996 Jun; 5(3):144-56. PubMed ID: 8805077
[No Abstract] [Full Text] [Related]
19. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
Kiyono H; Bienenstock J; McGhee JR; Ernst PB
Reg Immunol; 1992; 4(2):54-62. PubMed ID: 1503889
[No Abstract] [Full Text] [Related]
20. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
Belyakov IM; Ahlers JD
Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
